BUSULFAN, CYCLOPHOSPHAMIDE AND MELPHALAN AS CONDITIONING REGIMEN FOR BONE MARROW TRANSPLANTATION IN CHILDREN WITH MYELODYSPLASTIC SYNDROMES.